Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Oxypeucedanin ((+-)-Oxypeucedanin) has novel anticancer effect, mediated via induction of G2-M cell cycle arrest and apoptosis in human prostate carcinoma DU145 cells. 2. Oxypeucedanin is a kind of open-channel blocker of the hKv1.5 channel and it prolongs the APD; therefore, it is an excellent candidate as an antiarrhythmic drug for atrial fibrillation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 68.00 | |
5 mg | In stock | $ 165.00 | |
10 mg | In stock | $ 283.00 | |
25 mg | In stock | $ 479.00 | |
50 mg | In stock | $ 688.00 | |
100 mg | In stock | $ 957.00 |
Description | 1. Oxypeucedanin ((+-)-Oxypeucedanin) has novel anticancer effect, mediated via induction of G2-M cell cycle arrest and apoptosis in human prostate carcinoma DU145 cells. 2. Oxypeucedanin is a kind of open-channel blocker of the hKv1.5 channel and it prolongs the APD; therefore, it is an excellent candidate as an antiarrhythmic drug for atrial fibrillation. |
Source |
Synonyms | (+-)-Oxypeucedanin, Oxypeucadanin |
Molecular Weight | 286.28 |
Formula | C16H14O5 |
CAS No. | 737-52-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 83.8 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Oxypeucedanin 737-52-0 Membrane transporter/Ion channel Potassium Channel atrial fibrillation cardiac action potential duration (+-)-Oxypeucedanin APD KcsA antiarrhythmic Inhibitor inhibit Oxypeucadanin Blocker inhibitor